Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.16 USD | -1.24% | +2.04% | -38.54% |
06:11pm | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
03:14pm | Oppenheimer Cuts Teladoc's Price Target to $21 From $26, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.54% | 2.26B | |
+42.87% | 2.63B | |
+23.82% | 520M | |
+42.77% | 467M | |
-64.42% | 160M | |
-31.65% | 87.05M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- UBS Lowers Teladoc's Price Target to $135 From $142 on Margin Expectations; Neutral Rating Kept